+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

AI in Oncology Market Size, Share & Trends Analysis Report by Component Type (Software Solutions, Hardware), Cancer Type (Breast Cancer, Lung Cancer), Application, End-use, and Region with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 150 Pages
  • May 2025
  • Region: Global
  • Grand View Research
  • ID: 5943907
REQUEST CUSTOMIZATION
Description Jump to:
The AI in Oncology Market was valued at USD 4.18 billion in 2024, and is projected to reach USD 19.17 billion by 2030, rising at a CAGR of 26.17%. The market is anticipated to witness significant growth owing to increasing prevalence of cancer among the global population, propelling the need to develop technologically advanced products to diagnose, treat, and analyze cancer. For instance, the International Agency for Research on Cancer (IARC) expects over 20.7 million new cases in 2023. Moreover, AI enables early detection, crucial for lowering mortality, especially through efficient screening programs.

Emerging markets are witnessing a rising prevalence of cancer due to various factors, including lifestyle changes & aging populations. The surge in cancer cases in these markets creates a demand for advanced technologies like AI in oncology to improve early detection, personalized treatment, and overall patient outcomes. For instance, in January 2024, India's first AI-Precision Oncology Centre (POC) was launched at Apollo Cancer Centre in Bengaluru. The POC will utilize the vast possibilities offered by AI to help oncologists, patients, and caregivers achieve the best possible results within a specified time frame.

AI is transforming the field of oncology by integrating vast datasets from multi-omics analyses with the latest developments in deep learning and high-performance computing techniques. AI applications are expanding to include new detection, screening, diagnosis, and classification approaches, cancer genomics characterization, tumor microenvironment analysis, prognostic and predictive biomarkers assessment, and strategies for follow-up and drug discovery. For instance, in October 2022, Model Medicines launched an oncology program focusing on identifying and developing therapeutics against two epigenetic and oncogenic targets, focusing on applications for solid and hematological malignancies.

The major players operating in the market are adopting strategies such as collaborations and partnerships with a major focus on development of newer products to aid in the early diagnosis of cancer, meet rising demand, and enhance research and development pipeline. For instance, in December 2022, AstraZeneca collaborated with Clinithink to launch an AI project for lung cancer. This project aims to detect lung cancer at an early stage to aid in the developing of effective treatment.

Furthermore, in November 2022, Google Health entered into a partnership with iCAD, Inc. for the improvement of breast cancer screening using the company’s artificial intelligence technology. Additionally, a number of public and private organizations are focusing on funding and investment for R&D in AI-based oncology screening products. For instance, in March 2023, Artera received funding of USD 90 million for the launch and distribution of the ArteraAI Prostate Test, the first developed test for predicting therapy in localized prostate cancer.

AI In Oncology Market Report Highlights

  • Based on component type, the software solutions segment is anticipated to grow at the fastest CAGR over the forecast period, owing to increasing adoption of software solutions for a wide number of applications due to the better outcomes offered by this component
  • Based on cancer type, the prostate cancer segment is anticipated to grow at the fastest CAGR over the forecast period in the market with rising prevalence amongst the population. Prostate cancer generally affects 13 out of every 100 men in the U.S., according to the data published by CDC
  • Based on application type, the research and development segment is expected to grow at the lucrative CAGR over the forecast period. This is attributable to the widespread adoption and amalgamation of advanced AI-enabled algorithms in pharmaceutical companies
  • Based on end-use, the hospitals dominated the market and registered the fastest growth owing to growing number of companies collaborating or introducing AI-powered cancer care solutions in hospitals
  • North America dominated the market due to the availability of favorable government initiatives and digital infrastructure to provide digital solutions to patients

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment scope
1.1.2 Regional scope
1.1.3 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 Research Assumptions
1.8 List of Secondary Sources
1.9 List of Abbreviations
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3 AI In Oncology Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market analysis
3.2 Market Dynamics
3.2.1 Market drivers analysis
3.2.2 Market restraint analysis
3.2.3 Market opportunity analysis
3.2.4 Market challenges analysis
3.3 AI In Oncology: Market Analysis Tools
3.3.1 Industry analysis - Porter’s
3.3.2 PESTLE analysis
3.4 Regulatory Framework
3.5 Case studies
Chapter 4 AI In Oncology Market Segment Analysis, By Component, 2018-2030 (USD Million)
4.1 Definition and Scope
4.2 Component Type Market Share Analysis, 2024 & 2030
4.3 Segment Dashboard
4.4 Global AI In Oncology Market, by Component, 2018 to 2030
4.5 Software Solutions
4.5.1 Software solutions market estimates and forecast, 2018-2030 (USD Million)
4.6 Hardware
4.6.1 Hardware market estimates and forecast, 2018-2030 (USD Million)
4.7 Services
4.7.1 Services market estimates and forecast, 2018-2030 (USD Million)
Chapter 5 AI In Oncology Market Segment Analysis, By Cancer Type, 2018-2030 (USD Million)
5.1 Definition and Scope
5.2 Cancer Type Market Share Analysis, 2024 & 2030
5.3 Segment Dashboard
5.4 Global AI In Oncology Market, by Cancer Type, 2018 to 2030
5.5 Breast Cancer
5.5.1 Breast cancer market estimates and forecast, 2018-2030 (USD Million)
5.6 Lung Cancer
5.6.1 Lung cancer market estimates and forecast, 2018-2030 (USD Million)
5.7 Prostate Cancer
5.7.1 Prostate cancer market estimates and forecast, 2018-2030 (USD Million)
5.8 Colorectal Cancer
5.8.1 Colorectal cancer market estimates and forecast, 2018-2030 (USD Million)
5.9 Brain Tumor
5.9.1 Brain tumor market estimates and forecast, 2018-2030 (USD Million)
5.10 Others
5.10.1 Others market estimates and forecast, 2018-2030 (USD Million)
Chapter 6 AI In Oncology Market Segment Analysis, By Application, 2018-2030 (USD Million)
6.1 Definition and Scope
6.2 Application Market Share Analysis, 2024 & 2030
6.3 Segment Dashboard
6.4 Global AI In Oncology Market, by Application, 2018 to 2030
6.5 Diagnostics (Pathology, Cancer Radiology)
6.5.1 Diagnostics (pathology, cancer radiology) market estimates and forecast, 2018-2030 (USD Million)
6.6 Radiation Therapy (Radiotherapy)
6.6.1 Radiation therapy (radiotherapy) market estimates and forecast, 2018-2030 (USD Million)
6.7 Research & Development (Drug Design, Development Process, etc.)
6.7.1 Research & development (drug design, development process, etc.) market estimates and forecast, 2018-2030 (USD Million)
6.8 Chemotherapy
6.8.1 Chemotherapy market estimates and forecast, 2018-2030 (USD Million)
6.9 Immunotherapy
6.8.1 Immunotherapy market estimates and forecast, 2018-2030 (USD Million)
Chapter 7 AI In Oncology Market Segment Analysis, By End Use Type, 2018-2030 (USD Million)
7.1 Definition and Scope
7.2 Application Market Share Analysis, 2024 & 2030
7.3 Segment Dashboard
7.4 Global AI In Oncology Market, by Application, 2018 to 2030
7.5 Hospitals
7.5.1 Hospitals market estimates and forecast, 2018-2030 (USD Million)
7.6 Surgical Centers & Medical Institutes
7.6.1 Surgical centers & medical institutes market estimates and forecast, 2018-2030 (USD Million)
7.7 Others (Pharmaceutical Companies, Research Institutes & Training Centers)
7.7.1 Others (pharmaceutical companies, research institutes & training centers) market estimates and forecast, 2018-2030 (USD Million)
Chapter 8. AI In Oncology Market Segment Analysis, By Region, By Component, By Cancer Type, By Application, By End-use, 2018-2030 (USD Million)
8.1. Definition & Scope
8.2. Regional Market Share Analysis, 2024 & 2030
8.3. Regional Market Dashboard
8.4. Regional Market Snapshot
8.5. SWOT Analysis
8.6. North America
8.6.1. North America Healthcare AI in Oncology Market, 2018-2030 (USD Million)
8.6.2. U.S.
8.6.2.1. Key Country Dynamic
8.6.2.2. Regulatory Framework
8.6.2.3. Competitive Insights
8.6.2.4. U.S. Healthcare AI in Oncology Market, 2018-2030 (USD Million)
8.6.3. Canada
8.6.3.1. Key Country Dynamic
8.6.3.2. Regulatory Framework
8.6.3.3. Competitive Insights
8.6.3.4. Canada Healthcare AI in Oncology Market, 2018-2030 (USD Million)
8.7. Europe
8.7.1. Europe Healthcare AI in Oncology Market, 2018-2030 (USD Million)
8.7.2. Germany
8.7.2.1. Key Country Dynamic
8.7.2.2. Regulatory Framework
8.7.2.3. Competitive Insights
8.7.2.4. Germany Healthcare AI in Oncology Market, 2018-2030 (USD Million)
8.7.3. UK
8.7.3.1. Key Country Dynamic
8.7.3.2. Regulatory Framework
8.7.3.3. Competitive Insights
8.7.3.4. UK Healthcare AI in Oncology Market, 2018-2030 (USD Million)
8.7.4. France
8.7.4.1. Key Country Dynamic
8.7.4.2. Regulatory Framework
8.7.4.3. Competitive Insights
8.7.4.4. France Healthcare AI in Oncology Market, 2018-2030 (USD Million)
8.7.5. Italy
8.7.5.1. Key Country Dynamic
8.7.5.2. Regulatory Framework
8.7.5.3. Competitive Insights
8.7.5.4. Italy Healthcare AI in Oncology Market, 2018-2030 (USD Million)
8.7.6. Spain
8.7.6.1. Key Country Dynamic
8.7.6.2. Regulatory Framework
8.7.6.3. Competitive Insights
8.7.6.4. Spain Healthcare AI in Oncology Market, 2018-2030 (USD Million)
8.7.7. Denmark
8.7.7.1. Key Country Dynamic
8.7.7.2. Regulatory Framework
8.7.7.3. Competitive Insights
8.7.7.4. Denmark Healthcare AI in Oncology Market, 2018-2030 (USD Million)
8.7.8. Sweden
8.7.8.1. Key Country Dynamic
8.7.8.2. Regulatory Framework
8.7.8.3. Competitive Insights
8.7.8.4. Sweden Healthcare AI in Oncology Market, 2018-2030 (USD Million)
8.7.9. Norway
8.7.9.1. Key Country Dynamic
8.7.9.2. Regulatory Framework
8.7.9.3. Competitive Insights
8.7.9.4. Norway Healthcare AI in Oncology Market, 2018-2030 (USD Million)
8.8. Asia Pacific
8.8.1. Asia Pacific Healthcare AI in Oncology Market, 2018-2030 (USD Million)
8.8.2. Japan
8.8.2.1. Key Country Dynamic
8.8.2.2. Regulatory Framework
8.8.2.3. Competitive Insights
8.8.2.4. Japan Healthcare AI in Oncology Market, 2018-2030 (USD Million)
8.8.3. China
8.8.3.1. Key Country Dynamic
8.8.3.2. Regulatory Framework
8.8.3.3. Competitive Insights
8.8.3.4. China Healthcare AI in Oncology Market, 2018-2030 (USD Million)
8.8.4. India
8.8.4.1. Key Country Dynamic
8.8.4.2. Regulatory Framework
8.8.4.3. Competitive Insights
8.8.4.4. India Healthcare AI in Oncology Market, 2018-2030 (USD Million)
8.8.5. South Korea
8.8.5.1. Key Country Dynamic
8.8.5.2. Regulatory Framework
8.8.5.3. Competitive Insights
8.8.5.4. South Korea Healthcare AI in Oncology Market, 2018-2030 (USD Million)
8.8.6. Australia
8.8.6.1. Key Country Dynamic
8.8.6.2. Regulatory Framework
8.8.6.3. Competitive Insights
8.8.6.4. Australia Healthcare AI in Oncology Market, 2018-2030 (USD Million)
8.8.7. Thailand
8.8.7.1. Key Country Dynamic
8.8.7.2. Regulatory Framework
8.8.7.3. Competitive Insights
8.8.7.4. Thailand Healthcare AI in Oncology Market, 2018-2030 (USD Million)
8.9. Latin America
8.9.1. Latin America Healthcare AI in Oncology Market, 2018-2030 (USD Million)
8.9.2. Brazil
8.9.2.1. Key Country Dynamic
8.9.2.2. Regulatory Framework
8.9.2.3. Competitive Insights
8.9.2.4. Brazil Healthcare AI in Oncology Market, 2018-2030 (USD Million)
8.9.3. Mexico
8.9.3.1. Key Country Dynamic
8.9.3.2. Regulatory Framework
8.9.3.3. Competitive Insights
8.9.3.4. Mexico Healthcare AI in Oncology Market, 2018-2030 (USD Million)
8.9.4. Argentina
8.9.4.1. Key Country Dynamic
8.9.4.2. Regulatory Framework
8.9.4.3. Competitive Insights
8.9.4.4. Argentina Healthcare AI in Oncology Market, 2018-2030 (USD Million)
8.10. MEA
8.10.1. MEA Healthcare AI in Oncology Market, 2018-2030 (USD Million)
8.10.2. South Africa
8.10.2.1. Key Country Dynamic
8.10.2.2. Regulatory Framework
8.10.2.3. Competitive Insights
8.10.2.4. South Africa Healthcare AI in Oncology Market, 2018-2030 (USD Million)
8.10.3. Saudi Arabia
8.10.3.1. Key Country Dynamic
8.10.3.2. Regulatory Framework
8.10.3.3. Competitive Insight
8.10.3.4. Saudi Arabia Healthcare AI in Oncology Market, 2018-2030 (USD Million)
8.10.4. UAE
8.10.4.1. Key Country Dynamic
8.10.4.2. Regulatory Framework
8.10.4.3. Competitive Insights
8.10.4.4. UAE Healthcare AI in Oncology Market, 2018-2030 (USD Million)
8.10.5. Kuwait
8.10.5.1. Key Country Dynamic
8.10.5.2. Regulatory Framework
8.10.5.3. Competitive Insights
8.10.5.4. Kuwait Healthcare AI in Oncology Market, 2018-2030 (USD Million)
Chapter 9. AI In Oncology Market - Competitive Analysis
9.1. Recent Developments & Impact Analysis, by Key Market Participants
9.2. Company Categorization
9.3. Company Profiles
9.3.1. Azra AI
9.3.1.1. Overview
9.3.1.2. Financial Performance
9.3.1.3. Service Benchmarking
9.3.1.4. Strategic Initiatives
9.3.2. IBM
9.3.2.1. Overview
9.3.2.2. Financial Performance
9.3.2.3. Service Benchmarking
9.3.2.4. Strategic Initiatives
9.3.3. Siemens Healthcare GmbH
9.3.3.1. Overview
9.3.3.2. Financial Performance
9.3.3.3. Service Benchmarking
9.3.3.4. Strategic Initiatives
9.3.4. Intel Corporation
9.3.4.1. Overview
9.3.4.2. Financial Performance
9.3.4.3. Service Benchmarking
9.3.4.4. Strategic Initiatives
9.3.5. GE HealthCare
9.3.5.1. Overview
9.3.5.2. Financial Performance
9.3.5.3. Service Benchmarking
9.3.5.4. Strategic Initiatives
9.3.6. NVIDIA Corporation
9.3.6.1. Overview
9.3.6.2. Financial Performance
9.3.6.3. Service Benchmarking
9.3.6.4. Strategic Initiatives
9.3.7. Digital Diagnostics Inc.
9.3.7.1. Overview
9.3.7.2. Financial Performance
9.3.7.3. Service Benchmarking
9.3.7.4. Strategic Initiatives
9.3.8. ConcertAI
9.3.8.1. Overview
9.3.8.2. Financial Performance
9.3.8.3. Service Benchmarking
9.3.8.4. Strategic Initiatives
9.3.9. Median Technologies
9.3.9.1. Overview
9.3.9.2. Financial Performance
9.3.9.3. Service Benchmarking
9.3.9.4. Strategic Initiatives
9.3.10. PathAI
9.3.10.1. Overview
9.3.10.2. Financial Performance
9.3.10.3. Service Benchmarking
9.3.10.4. Strategic Initiatives
9.3.11. MVision AI
9.3.11.1. Overview
9.3.11.2. Financial Performance
9.3.11.3. Service Benchmarking
9.3.11.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global ai in oncology market, by region, 2018-2030 (USD Million)
Table 4 Global ai in oncology market, by component, 2018-2030 (USD Million)
Table 5 Global ai in oncology market, by cancer type, 2018-2030 (USD Million)
Table 6 Global ai in oncology market, by application, 2018-2030 (USD Million)
Table 7 Global ai in oncology market, by end use, 2018-2030 (USD Million)
Table 8 North America AI in oncology market, by region, 2018-2030 (USD Million)
Table 9 North America AI in oncology market, by component, 2018-2030 (USD Million)
Table 10 North America AI in oncology market, by cancer type, 2018-2030 (USD Million)
Table 11 North America AI in oncology market, by application, 2018-2030 (USD Million)
Table 12 North America AI in oncology market, by end-use, 2018-2030 (USD Million)
Table 13 U.S. AI in oncology market, by component, 2018-2030 (USD Million)
Table 14 U.S. AI in oncology market, by application, 2018-2030 (USD Million)
Table 15 U.S. AI in oncology market, by cancer type, 2018-2030 (USD Million)
Table 16 U.S. AI in oncology market, by end-use, 2018-2030 (USD Million)
Table 17 Canada AI in oncology market, by component, 2018-2030 (USD Million)
Table 18 Canada AI in oncology market, by application, 2018-2030 (USD Million)
Table 19 Canada AI in oncology market, by cancer type, 2018-2030 (USD Million)
Table 20 Canada AI in oncology market, by end-use, 2018-2030 (USD Million)
Table 21 Europe AI in oncology market, by region, 2018-2030 (USD Million)
Table 22 Europe AI in oncology market, by component, 2018-2030 (USD Million)
Table 23 Europe AI in oncology market, by application, 2018-2030 (USD Million)
Table 24 Europe AI in oncology market, by cancer type, 2018-2030 (USD Million)
Table 25 Europe AI in oncology market, by end-use, 2018-2030 (USD Million)
Table 26 Germany AI in oncology market, by component, 2018-2030 (USD Million)
Table 27 Germany AI in oncology market, by application, 2018-2030 (USD Million)
Table 28 Germany AI in oncology market, by cancer type, 2018-2030 (USD Million)
Table 29 Germany AI in oncology market, by end-use, 2018-2030 (USD Million)
Table 30 UK AI in oncology market, by component, 2018-2030 (USD Million)
Table 31 UK AI in oncology market, by application, 2018-2030 (USD Million)
Table 32 UK AI in oncology market, by cancer type, 2018-2030 (USD Million)
Table 33 UK AI in oncology market, by end-use, 2018-2030 (USD Million)
Table 34 France AI in oncology market, by component, 2018-2030 (USD Million)
Table 35 France AI in oncology market, by application, 2018-2030 (USD Million)
Table 36 France AI in oncology market, by cancer type, 2018-2030 (USD Million)
Table 37 France AI in oncology market, by end-use, 2018-2030 (USD Million)
Table 38 Italy AI in oncology market, by component, 2018-2030 (USD Million)
Table 39 Italy AI in oncology market, by application, 2018-2030 (USD Million)
Table 40 Italy AI in oncology market, by cancer type, 2018-2030 (USD Million)
Table 41 Italy AI in oncology market, by end-use, 2018-2030 (USD Million)
Table 42 Spain AI in oncology market, by component, 2018-2030 (USD Million)
Table 43 Spain AI in oncology market, by application, 2018-2030 (USD Million)
Table 44 Spain AI in oncology market, by cancer type, 2018-2030 (USD Million)
Table 45 Spain AI in oncology market, by end-use, 2018-2030 (USD Million)
Table 46 Denmark AI in oncology market, by component, 2018-2030 (USD Million)
Table 47 Denmark AI in oncology market, by application, 2018-2030 (USD Million)
Table 48 Denmark AI in oncology market, by cancer type, 2018-2030 (USD Million)
Table 49 Denmark AI in oncology market, by end-use, 2018-2030 (USD Million)
Table 50 Sweden AI in oncology market, by component, 2018-2030 (USD Million)
Table 51 Sweden AI in oncology market, by application, 2018-2030 (USD Million)
Table 52 Sweden AI in oncology market, by cancer type, 2018-2030 (USD Million)
Table 53 Sweden AI in oncology market, by end-use, 2018-2030 (USD Million)
Table 54 Norway AI in oncology market, by component, 2018-2030 (USD Million)
Table 55 Norway AI in oncology market, by application, 2018-2030 (USD Million)
Table 56 Norway AI in oncology market, by cancer type, 2018-2030 (USD Million)
Table 57 Norway AI in oncology market, by end-use, 2018-2030 (USD Million)
Table 58 Asia Pacific AI in oncology market, by region, 2018-2030 (USD Million)
Table 59 Asia Pacific AI in oncology market, by component, 2018-2030 (USD Million)
Table 60 Asia Pacific AI in oncology market, by application, 2018-2030 (USD Million)
Table 61 Asia Pacific AI in oncology market, by cancer type, 2018-2030 (USD Million)
Table 62 Asia Pacific AI in oncology market, by end-use, 2018-2030 (USD Million)
Table 63 China AI in oncology market, by component, 2018-2030 (USD Million)
Table 64 China AI in oncology market, by application, 2018-2030 (USD Million)
Table 65 China AI in oncology market, by cancer type, 2018-2030 (USD Million)
Table 66 China AI in oncology market, by end-use, 2018-2030 (USD Million)
Table 67 Japan AI in oncology market, by component, 2018-2030 (USD Million)
Table 68 Japan AI in oncology market, by application, 2018-2030 (USD Million)
Table 69 Japan AI in oncology market, by cancer type, 2018-2030 (USD Million)
Table 70 Japan AI in oncology market, by end-use, 2018-2030 (USD Million)
Table 71 India AI in oncology market, by component, 2018-2030 (USD Million)
Table 72 India AI in oncology market, by application, 2018-2030 (USD Million)
Table 73 India AI in oncology market, by cancer type, 2018-2030 (USD Million)
Table 74 India AI in oncology market, by end-use, 2018-2030 (USD Million)
Table 75 South Korea AI in oncology market, by component, 2018-2030 (USD Million)
Table 76 South Korea AI in oncology market, by application, 2018-2030 (USD Million)
Table 77 South Korea AI in oncology market, by cancer type, 2018-2030 (USD Million)
Table 78 South Korea AI in oncology market, by end-use, 2018-2030 (USD Million)
Table 79 Australia AI in oncology market, by component, 2018-2030 (USD Million)
Table 80 Australia AI in oncology market, by application, 2018-2030 (USD Million)
Table 81 Australia AI in oncology market, by cancer type, 2018-2030 (USD Million)
Table 82 Australia AI in oncology market, by end-use, 2018-2030 (USD Million)
Table 83 Thailand AI in oncology market, by component, 2018-2030 (USD Million)
Table 84 Thailand AI in oncology market, by application, 2018-2030 (USD Million)
Table 85 Thailand AI in oncology market, by cancer type, 2018-2030 (USD Million)
Table 86 Thailand AI in oncology market, by end-use, 2018-2030 (USD Million)
Table 87 Latin America AI in oncology market, by region, 2018-2030 (USD Million)
Table 88 Latin America AI in oncology market, by component, 2018-2030 (USD Million)
Table 89 Latin America AI in oncology market, by application, 2018-2030 (USD Million)
Table 90 Latin America AI in oncology market, by cancer type, 2018-2030 (USD Million)
Table 91 Latin America AI in oncology market, by end-use, 2018-2030 (USD Million)
Table 92 Brazil AI in oncology market, by component, 2018-2030 (USD Million)
Table 93 Brazil AI in oncology market, by application, 2018-2030 (USD Million)
Table 94 Brazil AI in oncology market, by cancer type, 2018-2030 (USD Million)
Table 95 Brazil AI in oncology market, by end-use, 2018-2030 (USD Million)
Table 96 Mexico AI in oncology market, by component, 2018-2030 (USD Million)
Table 97 Mexico AI in oncology market, by application, 2018-2030 (USD Million)
Table 98 Mexico AI in oncology market, by cancer type, 2018-2030 (USD Million)
Table 99 Mexico AI in oncology market, by end-use, 2018-2030 (USD Million)
Table 100 Argentina AI in oncology market, by component, 2018-2030 (USD Million)
Table 101 Argentina AI in oncology market, by application, 2018-2030 (USD Million)
Table 102 Argentina AI in oncology market, by cancer type, 2018-2030 (USD Million)
Table 103 Argentina AI in oncology market, by end-use, 2018-2030 (USD Million)
Table 104 MEA AI in oncology market, by region, 2018-2030 (USD Million)
Table 105 MEA AI in oncology market, by component, 2018-2030 (USD Million)
Table 106 MEA AI in oncology market, by application, 2018-2030 (USD Million)
Table 107 MEA AI in oncology market, by cancer type, 2018-2030 (USD Million)
Table 108 MEA AI in oncology market, by end-use, 2018-2030 (USD Million)
Table 109 South Africa AI in oncology market, by component, 2018-2030 (USD Million)
Table 110 South Africa AI in oncology market, by application, 2018-2030 (USD Million)
Table 111 South Africa AI in oncology market, by cancer type, 2018-2030 (USD Million)
Table 112 South Africa AI in oncology market, by end-use, 2018-2030 (USD Million)
Table 113 Saudi Arabia AI in oncology market, by component, 2018-2030 (USD Million)
Table 114 Saudi Arabia AI in oncology market, by application, 2018-2030 (USD Million)
Table 115 Saudi Arabia AI in oncology market, by cancer type, 2018-2030 (USD Million)
Table 116 Saudi Arabia AI in oncology market, by end-use, 2018-2030 (USD Million)
Table 117 UAE AI in oncology market, by component, 2018-2030 (USD Million)
Table 118 UAE AI in oncology market, by application, 2018-2030 (USD Million)
Table 119 UAE AI in oncology market, by cancer type, 2018-2030 (USD Million)
Table 120 UAE AI in oncology market, by end-use, 2018-2030 (USD Million)
Table 121 Kuwait AI in oncology market, by component, 2018-2030 (USD Million)
Table 122 Kuwait AI in oncology market, by application, 2018-2030 (USD Million)
Table 123 Kuwait AI in oncology market, by cancer type, 2018-2030 (USD Million)
Table 124 Kuwait AI in oncology market, by end-use, 2018-2030 (USD Million)
List of Figures
Figure 1 AI in oncology market segmentation
Figure 2 Market research process
Figure 3 Information procurement
Figure 4 Commodity flow analysis
Figure 5 Parent market analysis
Figure 6 AI in oncology Market snapshot
Figure 7 AI in oncology Market segment snapshot
Figure 8 AI in oncology Market segment snapshot
Figure 9 AI in oncology Market competitive landscape snapshot
Figure 10 Market research process
Figure 11 Parent market outlook (USD Billion) (2024)
Figure 12 AI in oncology market dynamics
Figure 13 Areas of interest most likely to benefit from AI in the next 10 years
Figure 14 Anticipated Clinical Impact: Key Areas where AI is Poised to Make a Significant Difference
Figure 15 Comparison between AI-integrated healthcare and traditional healthcare
Figure 16 Porter’s Analysis
Figure 17 PESTEL Analysis
Figure 18 AI in oncology market, component outlook key takeaways (USD Million)
Figure 19 AI in oncology market: Component movement analysis, 2024 & 2030 (USD Million)
Figure 20 Software solutions market estimates and forecasts, 2018-2030 (USD Million)
Figure 21 Hardware market estimates and forecasts, 2018-2030 (USD Million)
Figure 22 Services market estimates and forecasts, 2018-2030 (USD Million)
Figure 23 AI in cancer diagnostics market, cancer type outlook key takeaways (USD Million)
Figure 24 AI in oncology market: Cancer type movement analysis, 2024 & 2030 (USD Million)
Figure 25 Breast cancer market estimates and forecasts, 2018-2030 (USD Million)
Figure 26 Lung cancer market estimates and forecasts, 2018-2030 (USD Million)
Figure 27 Prostate cancer market estimates and forecasts, 2018-2030 (USD Million)
Figure 28 Colorectal cancer market estimates and forecasts, 2018-2030 (USD Million)
Figure 29 Brain tumor market estimates and forecasts, 2018-2030 (USD Million)
Figure 30 Others market estimates and forecasts, 2018-2030 (USD Million)
Figure 31 AI in cancer diagnostics market, application outlook key takeaways (USD Million)
Figure 32 AI in oncology market: Application movement analysis, 2024 & 2030 (USD Million)
Figure 33 Diagnostics (pathology, cancer radiology) market estimates and forecasts, 2018-2030 (USD Million)
Figure 34 Radiation therapy (Radiotherapy) market estimates and forecasts, 2018-2030 (USD Million)
Figure 35 Chemotherapy market estimates and forecasts, 2018-2030 (USD Million)
Figure 36 Immunotherapy market estimates and forecasts, 2018-2030 (USD Million)
Figure 37 Research & development market estimates and forecasts, 2018-2030 (USD Million)
Figure 38 AI in oncology market, end-use outlook key takeaways (USD Million)
Figure 39 AI in oncology market: End-user movement analysis, 2024 & 2030 (USD Million)
Figure 40 Hospitals market estimates and forecasts, 2018-2030 (USD Million)
Figure 41 Surgical centers and medical institutes market estimates and forecasts, 2018-2030 (USD Million)
Figure 42 Others market estimates and forecasts, 2018-2030 (USD Million)
Figure 43 Regional marketplace: Key takeaways
Figure 44 AI in Oncology market: Regional outlook, 2024 & 2030 (USD Million)
Figure 45 AI in Oncology market: Regional outlook, 2024 & 2030 (USD Million)
Figure 46 North America AI in oncology market estimates and forecasts, 2018-2030 (USD Million)
Figure 47 Key country dynamics
Figure 48 U.S. AI in oncology market estimates and forecasts, 2018-2030 (USD billion)
Figure 49 U.S. AI in oncology market estimates and forecasts, 2018-2030 (USD Million)
Figure 50 Key country dynamics
Figure 51 Canada AI in oncology market estimates and forecasts, 2018-2030 (USD Million)
Figure 52 Europe AI in oncology market estimates and forecasts, 2018-2030 (USD Million)
Figure 53 Key country dynamics
Figure 54 UK AI in oncology market estimates and forecasts, 2018-2030 (USD Million)
Figure 55 Key country dynamics
Figure 56 Germany AI in oncology market estimates and forecasts, 2018-2030 (USD Million)
Figure 57 Key country dynamics
Figure 58 Spain AI In oncology market estimates and forecasts, 2018-2030 (USD Million)
Figure 59 Key country dynamics
Figure 60 France AI in oncology market estimates and forecasts, 2018-2030 (USD Million)
Figure 61 Key country dynamics
Figure 62 Italy AI in oncology market estimates and forecasts, 2018-2030 (USD Million )
Figure 63 Key country dynamics
Figure 64 Norway AI in oncology market estimates and forecasts, 2018-2030 (USD Million)
Figure 65 Key country dynamics
Figure 66 Denmark AI in oncology market estimates and forecasts, 2018-2030 (USD Million)
Figure 67 Key country dynamics
Figure 68 Sweden AI in oncology market estimates and forecasts, 2018-2030 (USD Million)
Figure 69 Asia Pacific AI in oncology market estimates and forecasts, 2018-2030 (USD Million )
Figure 70 Key country dynamics
Figure 71 Japan AI in oncology market estimates and forecasts, 2018-2030 (USD Million)
Figure 72 Key country dynamics
Figure 73 China AI in oncology market estimates and forecasts, 2018-2030 (USD Million)
Figure 74 Key country dynamics
Figure 75 India AI in oncology market estimates and forecasts, 2018-2030 (USD Million )
Figure 76 Key country dynamics
Figure 77 Australia AI in oncology market estimates and forecasts, 2018-2030 (USD Million )
Figure 78 Key country dynamics
Figure 79 South Korea AI in oncology market estimates and forecasts, 2018-2030 (USD Million )
Figure 80 Key country dynamics
Figure 81 Thailand AI in oncology market estimates and forecasts, 2018-2030 (USD Million)
Figure 82 Latin America AI in oncology market estimates and forecasts, 2018-2030 (USD Million )
Figure 83 Key country dynamics
Figure 84 Brazil AI in oncology market estimates and forecasts, 2018-2030 (USD Million)
Figure 85 Key country dynamics
Figure 86 Mexico AI in oncology market estimates and forecasts, 2018-2030 (USD Million )
Figure 87 Key country dynamics
Figure 88 Argentina AI in oncology market estimates and forecasts, 2018-2030 (USD Million )
Figure 89 MEA AI in oncology market estimates and forecasts, 2018-2030 (USD Million)
Figure 90 Key country dynamics
Figure 91 South Africa AI in oncology market estimates and forecasts, 2018-2030 (USD Million)
Figure 92 Key country dynamics
Figure 93 Saudi Arabia AI in oncology market estimates and forecasts, 2018-2030 (USD Million)
Figure 94 Key country dynamics
Figure 95 UAE AI in oncology market estimates and forecasts, 2018-2030 (USD Million)
Figure 96 Key country dynamics
Figure 97 Kuwait AI in oncology market estimates and forecasts, 2018-2030 (USD Million)
Figure 98 Key company categorization
Figure 99 Heat map analysis

Companies Mentioned

The major companies featured in this AI in Oncology market report include:
  • Azra AI
  • IBM
  • Siemens Healthcare GmbH
  • Intel Corporation
  • GE HealthCare
  • NVIDIA Corporation
  • Digital Diagnostics Inc.
  • ConcertAI
  • Median Technologies
  • PathAI
  • MVision AI

Table Information

Report AttributeDetails
No. of Pages150
PublishedMay 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 4.18 Billion
Forecasted Market Value ( USD ) by 2030 $ 19.17 Billion
Compound Annual Growth Rate26.1%
Regions CoveredGlobal
No. of Companies Mentioned12

Related Topics

Related Reports

Precision Oncology Market Size, Share & Trends Analysis Report By Product Type (Diagnostics, Therapeutics), By Cancer Type (Breast Cancer, Cervical Cancer, Prostate Cancer, Lung Cancer), By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Precision Oncology Market Size, Share & Trends Analysis Report By Product Type (Diagnostics, Therapeutics), By Cancer Type (Breast Cancer, Cervical Cancer, Prostate Cancer, Lung Cancer), By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 180 Pages
  • Global
From
AI in Oncology Market by Player Type (Integrated Suite), Application (Drug Discovery, De Novo Drug Design, Diagnosis, Precision Medicine, Genomic), Technology (CNN, NLP), Cancer Type (Lung), End User (Hospitals, Pharma), & Region - Global Forecast to 2030 - Product Image

AI in Oncology Market by Player Type (Integrated Suite), Application (Drug Discovery, De Novo Drug Design, Diagnosis, Precision Medicine, Genomic), Technology (CNN, NLP), Cancer Type (Lung), End User (Hospitals, Pharma), & Region - Global Forecast to 2030

  • Report
  • 581 Pages
  • Global
From
AI in Oncology Market Report and Forecast 2025-2034 - Product Image

AI in Oncology Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
AI in Oncology Market Industry Trends and Global Forecasts to 2035, by Type of Cancer, Type of End-Users and Key Geographical Regions - Product Image

AI in Oncology Market Industry Trends and Global Forecasts to 2035, by Type of Cancer, Type of End-Users and Key Geographical Regions

  • Report
  • 220 Pages
  • Global
From
AI in Oncology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

AI in Oncology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 172 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.